Hyperbaric Oxygen Treatment May Make Antiobiotics More Effective Against P. aeruginosa Infections, S
Exposing cystic fibrosis (CF) patients to high levels of oxygen through hyperbaric oxygen treatment may make Pseudomonas aeruginosa...
Link Found Between P. aeruginosa Infection and Disease Severity in CF Patients, Study Reports
Patients with cystic fibrosis (CF) whose lungs have never been colonized by the Pseudomonas aeruginosa bacterium have a milder form of...
Chronic P. Aeruginosa Infection Greatly Raises Risk of Flares in Non-CF Bronchiectasis, Study Shows
People with non-cystic fibrosis (CF) bronchiectasis are at a significantly greater risk of exacerbations if they have chronic infections...
AIT’s Inhaled Nitric Oxide Shows Potential in Fighting Bacterial Infection Prevalent in CF Patients
Inhaled nitric oxide (NO) was shown to be an effective antibacterial agent against Mycobacterium abscessus infection in preclinical...
Azithromycin Reduced Pulmonary Exacerbation Risk in Cystic Fibrosis
Azithromycin significantly reduced the risk for pulmonary exacerbations and resulted in sustained improvement in weight but had no effect...
Way Found to Use Antimicrobial Peptides, Part of Immune System, to Treat Bacterial Lung and Wound In
Antimicrobial peptides administered as tiny nanoparticles show promise in treating bacterial infections without risking making the...
Improving Antibiotic Strategies To Combat Respiratory Infections In Cystic Fibrosis Patients
Cystic fibrosis (CF) is an inherited, progressive disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR)...
Many CF Patients Have Long-term Staphylococcus Aureus Infections, Study Shows
Many cystic fibrosis patients have long-term Staphylococcus aureus infections, with the bacteria’s resistance to antibiotics fluctuating...
Bacterial changes early in life cause cystic fibrosis in kids
Bacterial changes begin in the first few years of life leading to the formation of cystic fibrosis, which makes children repeatedly prone...
Humanigen’s Inflammation Therapy Is Only Modestly Effective in CF Patients with an Infection, Trial
Humanigen’s anti-inflammatory therapy KB001-A is safe but only modestly effective in cystic fibrosis patients with a Pseudomonas...
